Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of Elsulfavirine in Healthy Volunteers and HIV-1 Patients
NCT02485509Phase 2Completed
- Sponsor
- Viriom Inc
- Start
- Mar 2013
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of elsufavirine in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Viriom Inc. Started Mar 2013; status: completed.
02
Drugs
elsufavirine
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT02485509.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02485509.